BECTON DICKINSON & CO is 21.6x more valuable than Pulse Biosciences, Inc. by market capitalization ($40.60 B vs $1.88 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | PLSE | BDX |
|---|---|---|
| Market cap | $1.88 B | $40.60 B |
| US-listed rank | #2150 | #377 |
| Revenue (latest FY) | $350.00K | $21.84B |
| Net income (latest FY) | -$72.78M | $1.68B |
| Net margin | -20794.6% | 7.7% |
| P/E (trailing FY) | - | 24.2 |
| SEC filings | 616 | 3,027 |
BECTON DICKINSON & CO is 21.6x more valuable than Pulse Biosciences, Inc. by market capitalization ($40.60 B vs $1.88 B).
In their latest fiscal years, Pulse Biosciences, Inc. reported $350.00K in revenue while BECTON DICKINSON & CO reported $21.84B.
Full pages: Pulse Biosciences, Inc. and BECTON DICKINSON & CO, or browse the full rankings.